An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females
Public ClinicalTrials.gov record NCT01403038. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Open-Label Study of the Effects of Elagolix on Ovarian Activity, Ovulation and Ovarian Reserve in Premenopausal Females
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label Phase 1 study in healthy premenopausal females evaluating the effects of different dosing regimens of elagolix on ovarian activity, ovulation, and ovarian reserve and to assess the effect of elagolix on selected endocrine/hormone levels.
Study identification
- NCT ID
- NCT01403038
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 216 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2011 (Type not available)
- Primary completion
- Oct 2012 (Actual)
- Completion
- Nov 2012 (Actual)
- Last update posted
- Jan 8, 2013
2011 – 2012
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 50805 | Colorado Springs | Colorado | 80910 | — |
| Site Reference ID/Investigator# 51270 | Colorado Springs | Colorado | 80917 | — |
| Site Reference ID/Investigator# 50884 | Denver | Colorado | 80246 | — |
| Site Reference ID/Investigator# 50404 | Lonetree | Colorado | 80124 | — |
| Site Reference ID/Investigator# 50904 | Miami | Florida | 33126 | — |
| Site Reference ID/Investigator# 50402 | South Miami | Florida | 33143 | — |
| Site Reference ID/Investigator# 50808 | Tampa | Florida | 33606 | — |
| Site Reference ID/Investigator# 50807 | Naperville | Illinois | 60540 | — |
| Site Reference ID/Investigator# 50804 | Oak Brook | Illinois | 60523 | — |
| Site Reference ID/Investigator# 50762 | Durham | North Carolina | 27713 | — |
| Site Reference ID/Investigator# 50403 | Winston-Salem | North Carolina | 27103 | — |
| Site Reference ID/Investigator# 50810 | Cincinnati | Ohio | 45267-0457 | — |
| Site Reference ID/Investigator# 50883 | Portland | Oregon | 97239 | — |
| Site Reference ID/Investigator# 50803 | Philadelphia | Pennsylvania | 19104 | — |
| Site Reference ID/Investigator# 51546 | Philadelphia | Pennsylvania | 19114 | — |
| Site Reference ID/Investigator# 50806 | San Antonio | Texas | 78229 | — |
| Site Reference ID/Investigator# 51342 | San Antonio | Texas | 78229 | — |
| Site Reference ID/Investigator# 50811 | Sandy City | Utah | 84070 | — |
| Site Reference ID/Investigator# 50902 | Norfolk | Virginia | 23507 | — |
| Site Reference ID/Investigator# 50882 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01403038, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 8, 2013 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01403038 live on ClinicalTrials.gov.